Key Companies Covered in the E-Clinical Solutions Market Research Report by Kenneth Research are Parexel International Corporation, eClinical Solutions LLC., Signant Health LLC, Datatrak Int., MaxisIT Inc, Advarra, Inc., FHI Clinical Inc., Clinical Ink, Inc., Oracle Corporation, eResearchTechnology, Inc. (Clario), and other key market players.
New York, July 19, 2022 (GLOBE NEWSWIRE) -- According to the World Bank, individuals using the internet raised from 40% of global population in 2015, to 60% of global population in 2020 and is estimated to rise significantly over the forecast period. Moreover, as of 2019, hospitals produce around 50 petabytes of data per year, and in less than two years healthcare data is projected to surpass the current data storage limit of the world.
Kenneth Research has published a detailed market report on ‘Global E-Clinical Solutions Market’ which includes the ongoing industry innovations and recent trends being adopted by the major industry players to achieve their business targets. Apart from that, the inclusive data on market size, growth rate, market revenue share, growth opportunities and challenges for the market players along with worldwide analysis on five major regions – North America, Latin America, Europe, Asia Pacific and Middle East & Africa has been provided in the report.
According to the World Health Organization, nearly 10 million people died of cancer across the globe in 2020. As a result, the rising cancer prevalence is estimated to drive the market growth. The global e-clinical solutions market is estimated to garner around USD 1.5 billion in revenue by 2031, by growing at a CAGR of ~13% over the forecast period i.e., 2022–2031. The growth of the market can be attributed to the upsurge in big data in the healthcare industry, rising number of clinical trials, rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and infectious diseases, and government emphasis on clinical research. Additionally, the market is expanding on the back of rising R&D spending by pharma-biotech businesses on drug development. For instance, a report by the World Bank stated that in 2020, 2.63% of global GDP was spent for research & development. The increasing demand to store this data in a secure way is driving the market significantly.
Get a Sample PDF of This Report @ https://www.kennethresearch.com/sample-request-10070550
Moreover, rising cases of data breaches in healthcare sector is fuelling the demand of e-clinical solutions. It was noticed that, from 2005 to 2019, the total number of individuals affected by healthcare data breaches was 249.09 million. Out of these, 157.40 million individuals were affected in the last five years alone and it is anticipated to increase more over the forecast period. Hence, this is estimated to be a prime factor to propel the growth of the global e-clinical solutions market. Further, rising cases of deaths due to chronic diseases is expected to be a prime factor to boost the market growth. It was noticed that approximately 17.9 million people died from CVDs in 2019, representing 32% of all global deaths.
Regionally, the global e-clinical solutions market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The North America region is estimated to witness significant growth over the forecast period on the back of rising government contributions to support clinical trials, continuous product development, and new product launches by e-clinical solution traders. In addition, growth in the number of partnerships for new drug development are further driving the demand for e-clinical solutions in the region. Further, the per capita disposable income among the major population over the region is increasing significantly and with that healthcare expenditure is rising as well. According to the data by The World Bank, in 2020, the disposable income per capita in North America region was USD 51,407. Hence, this is expected to fuel the market growth in the North America region significantly.
Browse to access In-depth research report on E-Clinical Solutions Market with detailed charts and figures: https://www.kennethresearch.com/report-details/eclinical-solutions-market/10070550
On the other hand, the e-clinical solutions market in the Asia Pacific region is predicted to witness the fastest growth during the forecast period. This growth can be attributed to a big urban population and an increase in diagnostic services in the region are also anticipated to increase hospital admissions, which is anticipated to increase the amount of data collected online. It is observed that the number of hospital beds available per 1000 people in Asia Pacific region has been rising throughout the years. In 2017, 4.5 beds were available per 1000 people and it is anticipated to increase more along with increasing hospital admissions over the forecast period.
The study further incorporates Y-O-Y growth, demand & supply and forecast future opportunity in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
The global e-clinical solutions market is segmented on the basis of delivery, into web-based, on-premise, and cloud-based. Out of these segments, the web-based segment is estimated to hold the largest market share over the forecast period. The growth of this segment can be attributed to related benefits, such as easy accessibility, usability, and lower investments required. As web-hosted goods are highly flexible to configure, providers can easily change or modify the way information is presented for various user groups. Further, rapid digitalization of enterprises across the world is estimated to boost the growth of web-based segment significantly. It was observed that approximately 95% of all workload was processed by cloud data centres in 2021.
Get a Sample PDF of Global E-Clinical Solutions Market @ https://www.kennethresearch.com/sample-request-10070550
Furthermore, the global e-clinical solutions market is segmented based on end-user into pharmaceutical/biopharma companies, contract research organizations (CROs), and hospitals. Out of these, the hospitals segment is expected to hold a substantial market share over the forecast period on the back of increasing awareness in healthcare, increasing diagnosis rate which results in increasing hospital admissions, and increasing health expenditure per capita among the global population. According to the World Bank statistics, health expenditure per capita reached USD 1121.81 in 2019 across the globe.
The global e-clinical solutions market is also segmented on the basis of product.
The Global Product Segment in Bullets
Enquiry before Buying This Report @ https://www.kennethresearch.com/sample-request-10070550
Some of the prominent players and their company profiling mentioned in the report include Parexel International Corporation, eClinical Solutions LLC., Signant Health LLC, Datatrak Int., MaxisIT Inc, Advarra, Inc., FHI Clinical Inc., Clinical Ink, Inc., Oracle Corporation, eResearchTechnology, Inc. (Clario), and others. The profiling enfolds growth opportunities, challenges, market trends, competitive analysis and positioning, along with the strategies used by them to stay ahead of their competitors.
One-Step ELISA Market Analysis by Application (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical Companies, and Research Centers); by Sample Type (Tissue Lysate, Plasma, & Serum, and Others); and by Target Molecule (Insulin, Albumin, IgG, TNF Alpha, Lysozyme, IL-6, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2022-2031
Disposable Syringes Market Segmentation by Type (General/Conventional, Safety, and Pre-Filled Syringes); by Syringe Tip (Luer-Lock, Slip, Eccentric, and Catheter Syringe Tips); by Application (Immunization, and Therapeutic Injections, and Others); by End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Pharmaceutical Companies, and Others)-Global Demand Analysis & Opportunity Outlook 2021-2031
Urinary Catheter Market Segmentation by Mechanism (Closed, and Open Systems); by Product (Intermittent, Indwelling, and External Catheters); by Gender (Male, and Female); by Application (Urinary Incontinence, Benign Prostate Hyperplasia & Prostate Surgeries, Spinal Cord Injury, and Others); and by End-User (Hospitals, Long Term Care Facilities, and Others)-Global Demand Analysis & Opportunity Outlook 2021-2031
Graphene Quantum Dots (GQDs) Market Segmentation by Form (Liquid, and Powder); by Application (Bio-Imaging, Cancer Therapeutics, Temperature Sensing, Drug Delivery, LEDs Lighter Converters, and Others); and by End-User (Consumer, Commercial, Healthcare, Defense, and Others)-Global Demand Analysis & Opportunity Outlook 2020-2030
External Pacemaker Market Segmentation by Product (Pulse Generator Device, and Leads); by Device (Single, Dual, and Triple Chamber); by Distribution Channel (Online, and Offline); and by End User (Hospitals, Ambulatory Surgical Centers, and Others)-Global Demand Analysis & Opportunity Outlook 2018-2028
Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Web: https://www.kennethresearch.com/
Yahoo Finance's Pras Subramanian discusses the latest auto news from the Tesla-only lane at the U.S.-Mexico border to Volkswagen replacing its CEO.
Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
Snap Inc. has never been an investor-friendly company as long as those investors weren't their founders, and the parent company of the Snapchat app made that even clearer Thursday.
Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).
One of Biden’s top energy aides confirmed Friday that no extension of releases from the Strategic Petroleum Reserve - scheduled to end this fall - is in the offing. But added a promise that it’s not going to lead to any supply shocks.
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla
At this time, I'd like to introduce Celso Goncalves, executive vice president and chief financial officer. During the quarter, we generated $633 million in free cash flow on $1.1 billion of adjusted EBITDA.
(Bloomberg) -- Volkswagen AG abruptly ousted Herbert Diess, its chief executive officer and architect of the auto industry’s biggest electrification effort, after repeated clashes with labor unions chipped away at his support with key stakeholders.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Int
U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.
ARKK ETF had a tough day, with nearly all of its holdings aside from Tesla in the red.
Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.
Tech giants Microsoft and Google have just taken additional hard decisions ahead of their earnings reports.
IBM (IBM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
After more than a year of testing in select cities, Amazon is launching its first wave of custom electric delivery vehicles.
A major Bluetooth headphone maker, Dongguan Koppo Electronics Co, has decided to shut down for good and dismiss all its workers, becoming the latest casualty of the economic headwinds, supply chain disruptions and trading woes that have hit China's manufacturing heartland. Koppo Electronics, which has operated its factory in the city of Dongguan in southern Guangdong province for 12 years, said it was ceasing operations partly because "a number of cross-border e-commerce clients have failed to m
In this article, we discuss the 10 stocks to buy before their earnings reports. If you want to read about some more stocks expected to gain following their quarterly results, go directly to 5 Stocks to Buy Before Their Earnings Reports. With the inflation in the US at a 40-year high and the Federal Reserve […]
Snap stock is falling double digits after a dismal second-quarter earnings report.